| James Lawton Iii, MD | |
|
619 19th St S, Birmingham, AL 35249-1900 | |
| (205) 934-5038 | |
| Not Available |
| Full Name | James Lawton Iii |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 619 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427263375 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD.202820 (Louisiana) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 26394 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Surgical Specialty Center Of Baton Rouge | Baton rouge, LA | Hospital |
| Baton Rouge General Medical Center | Baton rouge, LA | Hospital |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| North Oaks Medical Center, L L C | Hammond, LA | Hospital |
| Bolivar Medical Center | Cleveland, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baton Rouge Clinic, A Medical Corporation | 1254317001 | 218 |
| Baton Rouge Radiology Group Inc | 8729076229 | 28 |
| Neuromedical Center | 6103716477 | 86 |
| North Oaks Medical Center, Llc | 2466629522 | 228 |
| Ochsner Clinic Llc | 8224933619 | 2403 |
| Baton Rouge Radiology Group Inc | 8729076229 | 28 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Entity Name | Neuromedical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740216399 PECOS PAC ID: 6103716477 Enrollment ID: O20040318001606 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Entity Name | Baton Rouge Radiology Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407880339 PECOS PAC ID: 8729076229 Enrollment ID: O20040504000474 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Entity Name | Baton Rouge Clinic, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871546911 PECOS PAC ID: 1254317001 Enrollment ID: O20040624000911 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Entity Name | North Oaks Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164785648 PECOS PAC ID: 2466629522 Enrollment ID: O20120806000399 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Lawton Iii, MD 1156 Castlemaine Dr, Birmingham, AL 35226-5925 Ph: () - | James Lawton Iii, MD 619 19th St S, Birmingham, AL 35249-1900 Ph: (205) 934-5038 |
News Archive
Pfizer Inc. announced today that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety and efficacy study (B5161002) and an open-label extension study (B5161004).
Riverside Medical Center, one of the leading hospitals in Chicago area, unveils its Sweet Solution program this month. This diabetes prevention program will help men, women and children all over the Chicago hospital area prevent diabetes and lead healthier lifestyles.
A newly developed, genetically modified pig may hold the keys to the development of improved treatments and possibly even a cure for retinitis pigmentosa (RP), the most common inherited retinal disease in the United States.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
A pioneering Seven Day Service implemented by the Golden Jubilee National Hospital's Rehabilitation Department has celebrated its one year anniversary of making a positive impact on patient outcomes.
› Verified 5 days ago
Dr. Garrett Colby, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Jt N342, Birmingham, AL 35249 Phone: 205-934-3108 Fax: 205-975-4413 | |
Drexell H Boggs, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Rm: 2253, Birmingham, AL 35233 Phone: 205-975-9399 Fax: 205-975-5184 | |
James Walker, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Joseph Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Michelle M Mcnamara, MD Radiology Medicare: Medicare Enrolled Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-4011 | |
Sharda Mehar Bajaj, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1526 5th Ave S, Birmingham, AL 35233 Phone: 205-279-2860 | |
Gina Elizabeth Rebesco, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-975-0222 |